Venous and arterial thromboses, called as cancer-associated thromboembolism (CAT), are
common complications in cancer patients that are associated with high mortality. The cell …

Coronary artery disease exhibits growing mortality and morbidity worldwide despite the
advances in pharmacotherapy and coronary intervention. Coronary artery disease is …

Thrombotic diseases have a high rate of mortality and disability, and pose a serious threat to
global public health. Currently, most thrombolytic drugs especially protein drugs have a …

Background Thromboprophylaxis for medically ill patients during hospitalization and
postdischarge remains underutilized. Clinical decision support (CDS) may address this …

The field of thromboprophylaxis for acutely ill medical patients, including those hospitalized
for COVID-19, is rapidly evolving both in the inpatient setting and the immediate post …

Background Data on the association between atrial fibrillation (AF) and venous
thromboembolism (VTE) are controversial. Objectives The purpose of this study was to …

Despite revascularization and optimal secondary prevention, including dual antiplatelet
therapy (DAPT), patients with acute coronary syndrome (ACS) remain at risk of recurrent …

Abstract Purpose Factor XIa inhibitors are a promising novel class of anticoagulants that
attenuate pathological thrombosis with minimal interference with hemostasis. These effects …

Both antiplatelet and anticoagulation therapies have a unique history of preventing acute
myocardial infarction. A landmark randomized clinical trial, namely ISIS-2, had a strong …

Integrin β plays an important role in the pathogenesis of thrombosis and inflammation, and it
may be a shared pathogenic mechanism between arterial and venous thromboses. With the …